Trond Vidar Hansen

Trond Vidar Hansen is a Professor at the Department of Pharmacy, University of Oslo, and leads the LIPCHEM research group. He collaborates with institutions including the University of Bergen and Vestlandets Innovasjonsselskap through the VITADEL project, which recently received NOK 5,000,000 in verification support from the Research Council of Norway. His research focuses on the synthesis and biological evaluation of specialized pro-resolving lipid mediators derived from omega-3 fatty acids, with applications in inflammation resolution, neuroinflammation, and drug development.

• University: University of Oslo
• Department: Department of Pharmacy
• Research Group: LIPCHEM
• Collaborations: University of Bergen, Vestlandets Innovasjonsselskap

Research Interests:
H Hansen's work centers on the organic synthesis of bioactive lipid derivatives, particularly pro-resolving mediators from omega-3 polyunsaturated fatty acids. His team investigates their roles in inflammatory disease models, neuroinflammation, and PPAR receptor activation, aiming to develop therapeutic agents for conditions like chronic pain, diabetes, and neurodegenerative disorders. The research integrates stereoselective chemistry, biochemical profiling, and pharmacological evaluation to validate these mediators' clinical potential.

Recent Awards:

• 2025: NOK 2,000,000 verification support from Research Council of Norway
• 2025: Co-leader of NOK 5,000,000 VITADEL project

Publications:
His articles (2015–2024) reveal a focus on stereoselective synthesis of resolvins, protectins, and maresins, with applications in anti-inflammatory and neuroprotective therapies. Key subfields include omega-3 metabolite profiling, PPAR agonist design, and biosynthetic pathway elucidation, often utilizing human cell models and mouse disease models. Collaborative projects emphasize commercialization of academic research and translational medicine.